C

CXL Ophthalmics

7 employees

Epion is developing a minimally invasive treatment for an ectatic corneal disease.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Personal Health
Health Care
Wellness
Pharmaceutical
Life Science

Date founded

2012

Funding rounds raised

Total raised

$32M

from 1 investors over 1 rounds

C

CXL Ophthalmics raised $32M on September 30, 2022

Investors: Global Health Investment Fund

FAQ